Cargando…
SCARB2 drives hepatocellular carcinoma tumor initiating cells via enhanced MYC transcriptional activity
CSCs (Cancer stem cells) with distinct metabolic features are considered to cause HCC (hepatocellular carcinoma) initiation, metastasis and therapeutic resistance. Here, we perform a metabolic gene CRISPR/Cas9 knockout library screen in tumorspheres derived from HCC cells and find that deletion of S...
Autores principales: | Wang, Feng, Gao, Yang, Xue, Situ, Zhao, Luyao, Jiang, Huimin, Zhang, Tingting, Li, Yunxuan, Zhao, Chenxi, Wu, Fan, Siqin, Tana, Liu, Ying, Wu, Jie, Yan, Yechao, Yuan, Jian, Jiang, Jian-dong, Li, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517016/ https://www.ncbi.nlm.nih.gov/pubmed/37739936 http://dx.doi.org/10.1038/s41467-023-41593-z |
Ejemplares similares
-
Meta-analysis of the association between SCARB1 polymorphism and fasting blood lipid levels
por: Ye, Li-Fang, et al.
Publicado: (2017) -
The SCARB1 rs5888 SNP and Serum Lipid Levels in the Guangxi Mulao and Han Populations
por: Wu, Dong-Feng, et al.
Publicado: (2012) -
Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features
por: Hopfner, Franziska, et al.
Publicado: (2011) -
The Maturation of Tumor Suppressor miR-497 in Hepatocellular Carcinoma is Inhibited by Oncogenic circRNA SCARB1
por: Zhu, Shuo, et al.
Publicado: (2021) -
SCARB2 variants and glucocerebrosidase activity in Parkinson’s disease
por: Alcalay, Roy N, et al.
Publicado: (2016)